BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24008295)

  • 1. The oncogenic role of hepatitis C virus.
    Koike K
    Recent Results Cancer Res; 2014; 193():97-111. PubMed ID: 24008295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
    Koike K
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Oncogenic Role of Hepatitis C Virus.
    Koike K; Tsutsumi T
    Recent Results Cancer Res; 2021; 217():91-105. PubMed ID: 33200363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
    Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
    Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies.
    Koike K
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S132-5. PubMed ID: 16234061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid metabolism and liver disease in hepatitis C viral infection.
    Koike K; Tsutsumi T; Yotsuyanagi H; Moriya K
    Oncology; 2010 Jul; 78 Suppl 1():24-30. PubMed ID: 20616580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis.
    Koike K; Tsutsumi T; Miyoshi H; Shinzawa S; Shintani Y; Fujie H; Yotsuyanagi H; Moriya K
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S87-91. PubMed ID: 18336672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
    Tarao K; Rino Y; Ohkawa S; Tamai S; Miyakawa K; Takakura H; Endo O; Yoshitsugu M; Watanabe N; Matsuzaki S
    Cancer; 2002 Mar; 94(6):1787-95. PubMed ID: 11920542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C virus infection and hepatocarcinogenesis].
    Szalay F
    Orv Hetil; 2010 Sep; 151(38):1524-9. PubMed ID: 20826376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HCV core gene transgenic mouse as a model for viral hepatocarcinogenesis].
    Koike K
    Nihon Rinsho; 2001 Jul; 59(7):1265-70. PubMed ID: 11494535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR; Oliveri F; Colombatto P; Bonino F
    Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-induced hepatocarcinogenesis.
    Bartosch B; Thimme R; Blum HE; Zoulim F
    J Hepatol; 2009 Oct; 51(4):810-20. PubMed ID: 19545926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
    Tabor E
    Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of viral hepatocarcinogenesis.
    Koike K; Tsutsumi T; Fujie H; Shintani Y; Kyoji M
    Oncology; 2002; 62 Suppl 1():29-37. PubMed ID: 11868782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathobiologic effects of hepatitis C.
    Gerber MA
    J Hepatol; 1995; 22(1 Suppl):83-6. PubMed ID: 7602083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hepatitis C virus in the development of hepatocellular carcinoma: transgenic approach to viral hepatocarcinogenesis.
    Koike K; Moriya K; Kimura S
    J Gastroenterol Hepatol; 2002 Apr; 17(4):394-400. PubMed ID: 11982718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatitis C virus infection and liver cancer.
    Lim EJ; Torresi J
    Recent Results Cancer Res; 2014; 193():113-33. PubMed ID: 24008296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.